Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER) by Cho, Eun-Ae, Au-Yeung, Annie, China, Carlos, Yosufi, Benafsha, Arkenau, Hendrik-Tobias, Moloney, Fergal J., Scolyer, Richard A., Raftery, Mark J., Deng, Jason Z., Morton, Stephen Winford, Damian, Diona L., Francis, Douglas J., Chesterman, Colin N., Barnetson, Ross St. C., Halliday, Gary M., Khachigian, Levon M., Cai, Hong, Ph. D. Massachusetts Institute of Technology, Hammond, Paula T

Get full text